Member Info for StarKnight

Alan Sugar eat
What platform are you on ? i haven't had any Accustem shares allocated as yet ?

Hi Jack

According to the RNS it states the Accustem shares will be granted on either the date of listing or within 2 months which ever is the earliest so the last date to receive them by is December 31st 2020

Hi busymum

They said early next yera listing for Accustem but as per earlier RNS it states Accustem shares on a 1:1 basis to be listed within 2 months or up until 31st December 2020 which ever is the earliest date ! I am with AJ Bell and I have not as yet received my Accustem shares so as they stated listing in 2021 that seems a bit strange ??? what do ya think ?

Paulcon

Good Afternoon to you to Sir !

I am very well thank you i hope you are too !

I thought it was a much more professional presentation and like you said coverd all aspects of the Deepverge portfolio.
I still cannot beleive the Sp is where its at with such great potential it should be flying in my opinion.
I stopped visiting LSE Chat as every time I tried to post it kept hanging with error messages along the lines of chat suspended due to demand. So frustrating !I bet the advertisers on LSE wer not happy with that ! Is it all fixed now do you know ?

Hey Paulcon long time no chat hows you ?

I agree it was a gret presentation much more professional.

I posted 2 questions on the Webinar
1.Gerard,seeing as one of your business model is to detect contamination in water sources how about having a sub division of your company that provides a solution to decontaminate the water using whatever anti-dote chemicals to neutralize the relevant contamination. You would be first to have a foot in the door which would be a new source of revenue globally ?

2. Gerard,great company and ideas.
Can labskin be modified to clone human eye surface ie the cornea so that your clients can test their products on cloned eye skin corneas therfore saving testing on animal eyes ?

Jonathan from Derbyshire advised that ther is such a thing named Holoclar

Thoughts please ?

Hi busymum3

Yeah I’ve had a really crap day today !! My platform AJ Bell has been down all day came up at 16.27 just as I was paper loss today of £20,000 I’m hurting badly licking a large hole !!!

I can buy I just bought £1K worth no problem at 17.5 p
This looks like a great investment bought in yesterday and well into the blue :-) GLA

Hi all
Some great posts on here thank you for you inputs much appreciated.
I can buy I just bought £1K worth no problem at 17.5 p
This looks like a great investment bought in yesterday and well into the blue :-) GLA

Hi busymum3 and all
I am with AJ Bell and I have had corporate action notifications but no Accustem shares as yet

Re posting

Hundal

Obviously you sold last week now you are regretting it !!! The RNS is not drivel !!! You are trying to deramp the SP so you can get back in lower !! You are not welcome on this board so Phuck 0ff

Excellent RNS Yeah BBC World Service and Sky News anyone got Kay Burleys number ?

Tiziana Life Sciences PLC

("Tiziana" or "the Company")

Tiziana Announces Initiation of Clinical Trial for COVID-19 Patients in Brazil with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
London/New York, 2 November 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces initiation of a collaborative clinical study investigating nasally administered Foralumab either alone or in combination with orally administered dexamethasone in COVID-19 patients in Brazil. In view of the importance and urgency, scientific teams at the Harvard Medical School, Santa Casa de Misericórdia de Santos Hospital (Jabaquara, Santos, Brazil) and at Tiziana are closely collaborating to facilitate initiation of this study in expedited time frames. This clinical trial will be coordinated by the team at INTRIALS, a leading, full-service Latin America Clinical Research Organisation, (CRO) based in Sao Paulo City, Brazil. The clinical data from this trial is expected to be available by the end of this year.

Dr. Shailubhai, CEO and CSO of Tiziana Life Sciences stated:

· "Brazil has reported almost 5.5 million Coronavirus cases and 159,000 deaths and is considered a global epicenter of the outbreak. Brazil is currently experiencing almost 1,000 deaths per day. Therefore, our clinical study is both timely and a potential life changer for COVID-19 patients. The scientific concept, through activation of nasal mucosal immunity via nasally administered Foralumab, aims to fight the virus in the respiratory tract and lungs". The clinical study will start dosing patients on 3 November 2020 with data expected to be available before the end of 2020
· Since reduced or defective levels of T regulatory (Tregs) cells in the blood seem to be associated with the severity of COVID-19 and acute respiratory distress syndrome (ARDS), nasally administered Foralumab, by acting locally, could potentially suppress a 'cytokine storm' and hyperinflammation in the respiratory tract and lungs of COVID-19 patients
· A patent application was filed in July 2020 to protect the potential use of nasally administered Foralumab for the treatment of COVID-19 either alone or in combination with other anti-viral drugs.

Dr Howard Weiner, who is the Robert L. Kroc Professor of Neurology at the Harvard Medical School, Director and Founder of the Partners Multiple Sclerosis Center and Co-Director of the Ann Romney Center for Neurologic Diseases at the Brigham & Women's Hospital, and a Scientific Advisor to the Company, commented: "Nasal administration of Foralumab to modulate the human immune system is a potentially transformative approach for treating patients with a variety of human diseases with dysregulated immune systems. Results from studies, conducted in our laboratory have established that nasal ad

Good morning all

Obviously people are concerned about the SP dropping but look at the global markets as a whole !! These are extra ordinary times we are going through worldwide with sars-cov-2 deadly virus laying waste to major established companies. The FTSE 100 was only modestly lower by the close on Friday but still marked its worst week since March with the index chalking up a fifth straight day of losses, down 4.48 points at 5,577.27. The S&P 500 was down 1.1% at 3,271.72 by 4.30pm UK time amid political uncertainty with the US presidential election looming and a continuing surge in Covid-19 cases.
Despite all this the BOD have stuck to their word and out of the ashes rises our glorious Phoenix Accustem Sciences !!!
Let’s all be positive !! We are going to do greatly in both Tiziana and our PHOENIX

@whimax

Absolutely outstanding excellent work and thank you for your efforts !! I too am so glad this week is over but when I saw on 29th October Dr Kunwar announces that it has allotted and issued 426,500 ordinary shares of 3 pence each ("New Ordinary Shares") credited as fully paid at a price of 35 pence per share in respect of the exercise of 426,500 options with an exercise price of 35 pence held by option holders, including 400,000 held by Dr Kunwar Shailubhai, Chief Executive Officer and Chief Scientific Officer of the Company; 20,000 held by Vaseem Palejwala, Director of Clinical Operations of the Company and 3,500 held by Jules Jacob, Senior Director, CMC & Non-Clinical Development of the Company.

Application will be made for the 426,500 New Ordinary Shares to be admitted to trading on AIM ("Admission"), and dealings are expected to commence on or around 4 November 2020. The New Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

I felt that if they are prepared to risk that amount of holding then it has got to be a safe punt !! You know what they say ‘m Follow the Money ‘.It’s now just Beer o’clock so have a great weekend all !!

Hi all,
Does anyone know when the capital reduction will take place ? with SP close of play at 145 the reduction presumably will take the SP even lower ?

Hi busymum

I agree with you on the SP holding up well as so are most of my other investments are in the red too !! The only blue ones I have are Remote Monitored Systems and EKF Diagnostics which are up and coming xx

Good morning busymum

Yes I will be glad when this demerger is over too. Exciting times ahead Tils is my main investment and what a Life Saving company they are x

ak12345

Monday 2nd November is ex entitlement date to receive Accustem shares.You cannot sell any Accustem shares untill they are listed on LSE Main market

Tee Pete

No one in their right mind will be selling tomorow Friday is the record date so if anyone sells they will have to pay the cost of same number Accustem share value to the buyers of their Tils Share !!!!